The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease
Authors
Keywords
-
Journal
NEUROGASTROENTEROLOGY AND MOTILITY
Volume 28, Issue 12, Pages 1765-1780
Publisher
Wiley
Online
2016-08-26
DOI
10.1111/nmo.12931
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex interferes with anticipatory nausea in a rat model.
- (2016) Cheryl L. Limebeer et al. BEHAVIORAL NEUROSCIENCE
- An update on PPAR activation by cannabinoids
- (2016) Saoirse Elizabeth O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- The Role of the Endocannabinoid System in the Brain–Gut Axis
- (2016) Keith A. Sharkey et al. GASTROENTEROLOGY
- Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome
- (2015) Yasuhiro Iwata et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity
- (2015) U Taschler et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation
- (2015) M Bashashati et al. BRITISH JOURNAL OF PHARMACOLOGY
- GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis
- (2015) J Kargl et al. BRITISH JOURNAL OF PHARMACOLOGY
- Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways
- (2015) Gen Zheng et al. EXPERIMENTAL NEUROLOGY
- Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage
- (2015) Oscar Sasso et al. FASEB JOURNAL
- N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis
- (2015) Mireille Alhouayek et al. FASEB JOURNAL
- Epigenetic Regulation of Genes That Modulate Chronic Stress-Induced Visceral Pain in the Peripheral Nervous System
- (2015) Shuangsong Hong et al. GASTROENTEROLOGY
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endocannabinoids — at the crossroads between the gut microbiota and host metabolism
- (2015) Patrice D. Cani et al. Nature Reviews Endocrinology
- The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents
- (2015) Y. S. Sakin et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The GPR55 antagonist CID16020046 protects against intestinal inflammation
- (2015) A. Stančić et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Neurobiological Interactions Between Stress and the Endocannabinoid System
- (2015) Maria Morena et al. NEUROPSYCHOPHARMACOLOGY
- Intra-visceral insular cortex 2-arachidonoylglycerol, but not N-arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats
- (2015) M.A. Sticht et al. NEUROSCIENCE
- Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [18F]MK-9470 PET Study
- (2015) Huynh Giao Ly et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Lactobacillus acidophilusNCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study
- (2014) T. Ringel-Kulka et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent
- (2014) Francesca Borrelli et al. BRITISH JOURNAL OF PHARMACOLOGY
- Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1receptors and TRPV1 channels
- (2014) Raffaele Capasso et al. BRITISH JOURNAL OF PHARMACOLOGY
- Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid
- (2014) Francesca Borrelli et al. CARCINOGENESIS
- Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohnʼs Disease
- (2014) Martin Storr et al. INFLAMMATORY BOWEL DISEASES
- Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
- (2014) M. Sałaga et al. Journal of Crohns & Colitis
- Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome
- (2014) Yingjie Jiang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats
- (2014) Chen-Chen Feng et al. PAIN
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- (2013) Francesca Borrelli et al. BIOCHEMICAL PHARMACOLOGY
- 3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis
- (2013) Aurélien Tourteau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study
- (2013) Timna Naftali et al. Clinical Gastroenterology and Hepatology
- Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability
- (2013) B.S. Harvey et al. CYTOKINE
- Faecal microbiota composition and host–microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome
- (2013) Jonna Jalanka-Tuovinen et al. GUT
- Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
- (2013) Giuseppe Esposito et al. GUT
- Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
- (2013) Jessica Ravikoff Allegretti et al. INFLAMMATORY BOWEL DISEASES
- Decreased enteric fatty acid amide hydrolase activity is associated with colonic inertia in slow transit constipation
- (2013) Shu-Cheng Zhang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides
- (2013) J. Fichna et al. NEUROGASTROENTEROLOGY AND MOTILITY
- A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice
- (2013) Kun Li et al. NEUROPHARMACOLOGY
- Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
- (2013) Barbara Romano et al. PHYTOMEDICINE
- Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study
- (2013) Jakub Fichna et al. PLoS One
- Anti-tumor Activity of the Novel Hexahydrocannabinol Analog LYR-8 in Human Colorectal Tumor Xenograft Is Mediated through the Inhibition of Akt and Hypoxia-Inducible Factor-1^|^#945; Activation
- (2012) Dinesh Thapa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
- (2012) Angelo A Izzo et al. BRITISH JOURNAL OF PHARMACOLOGY
- A potential role for GPR55 in gastrointestinal functions
- (2012) Rudolf Schicho et al. CURRENT OPINION IN PHARMACOLOGY
- O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms
- (2012) Julia Kargl et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
- (2012) Gabriella Aviello et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cannabinoid Receptor 1 in the Vagus Nerve Is Dispensable for Body Weight Homeostasis But Required for Normal Gastrointestinal Motility
- (2012) C. R. Vianna et al. JOURNAL OF NEUROSCIENCE
- Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea
- (2012) B. S. Wong et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice
- (2012) Rudolf Schicho et al. PHARMACOLOGY
- Cannabinoid receptors: nomenclature and pharmacological principles
- (2012) Linda Console-Bram et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
- (2012) Mireille Alhouayek et al. TRENDS IN MOLECULAR MEDICINE
- Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice
- (2011) M Bashashati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats
- (2011) Martin A Sticht et al. BRITISH JOURNAL OF PHARMACOLOGY
- Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer
- (2011) Lin Ye et al. CANCER LETTERS
- Cannabis use amongst patients with inflammatory bowel disease
- (2011) Simon Lal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
- (2011) Mireille Alhouayek et al. FASEB JOURNAL
- Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
- (2011) Banny S. Wong et al. GASTROENTEROLOGY
- High Tumour Cannabinoid CB1 Receptor Immunoreactivity Negatively Impacts Disease-Specific Survival in Stage II Microsatellite Stable Colorectal Cancer
- (2011) Sofia B. Gustafsson et al. PLoS One
- Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
- (2011) Daniele De Filippis et al. PLoS One
- The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis
- (2010) Ali Rezaie et al. Archives of Medical Science
- The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation andin vitromotility disturbances in rat colitis
- (2010) JM Jamontt et al. BRITISH JOURNAL OF PHARMACOLOGY
- The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment
- (2010) Rudolf Schicho et al. INFLAMMATORY BOWEL DISEASES
- Cannabinoid Receptor 1 Gene Polymorphism and Irritable Bowel Syndrome in the Korean Population
- (2010) Jae Myung Park et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Endocannabinoid system in the adult rat circumventricular areas: An immunohistochemical study
- (2010) Juan Suárez et al. JOURNAL OF COMPARATIVE NEUROLOGY
- New pathophysiological insights and modern treatment of IBD
- (2010) Matthias A. Engel et al. JOURNAL OF GASTROENTEROLOGY
- Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
- (2010) A. Alhamoruni et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The endocannabinoid system links gut microbiota to adipogenesis
- (2010) Giulio G Muccioli et al. Molecular Systems Biology
- The cannabinoid receptor agonist delta-9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients
- (2010) T. K. Klooker et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Cannabinoids and the gut: New developments and emerging concepts
- (2010) Angelo A. Izzo et al. PHARMACOLOGY & THERAPEUTICS
- Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies
- (2010) Rudolf Schicho et al. Expert Review of Clinical Pharmacology
- Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance
- (2009) Francesca Borrelli et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis
- (2009) Martin A. Storr et al. INFLAMMATORY BOWEL DISEASES
- Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon
- (2009) Antonietta Santoro et al. INTERNATIONAL JOURNAL OF CANCER
- Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
- (2009) Francesca Borrelli et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception
- (2009) P. S. Naidu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cannabinoid receptor 1 signalling dampens activity and mitochondrial transport in networks of enteric neurones
- (2009) w. boesmans et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice
- (2009) n. l. cluny et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Single Nucleotide Change in the Cannabinoid Receptor-1 (CNR1) Gene in Colorectal Cancer Outcome
- (2009) Fernando Bedoya et al. ONCOLOGY
- Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue
- (2009) Lucia Marquéz et al. PLoS One
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cannabidiol, extracted fromCannabis sativa, selectively inhibits inflammatory hypermotility in mice
- (2008) R Capasso et al. BRITISH JOURNAL OF PHARMACOLOGY
- Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
- (2008) D. Wang et al. CANCER RESEARCH
- Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor -Mediated Ceramide De novo Synthesis in Colon Cancer Cells
- (2008) F. Cianchi et al. CLINICAL CANCER RESEARCH
- Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
- (2008) Martin A. Storr et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1receptors and fatty acid amide hydrolase
- (2008) d. de filippis et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome
- (2008) m. a. storr et al. NEUROGASTROENTEROLOGY AND MOTILITY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started